Amedeo Smart

Free Medical Literature Service


 

Amedeo

Bladder Cancer

  Free Subscription

Articles published in
Int J Cancer
    July 2018
  1. KOUTROS S, Baris D, Waddell R, Freeman LEB, et al
    Potential effect modifiers of the arsenic-bladder cancer risk relationship.
    Int J Cancer. 2018 Jul 7. doi: 10.1002/ijc.31720.
    >> Share

  2. LIN C, Travis RC, Appleby PN, Tipper S, et al
    Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.
    Int J Cancer. 2018 Jul 4. doi: 10.1002/ijc.31650.
    >> Share

    May 2018
  3. TELEKA S, Haggstrom C, Nagel G, Bjorge T, et al
    Risk of bladder cancer by disease severity in relation to metabolic factors and smoking; a prospective pooled cohort study of 800,000 men and women.
    Int J Cancer. 2018 May 14. doi: 10.1002/ijc.31597.
    >> Share

    February 2018
  4. LIU X, Cheng X, Liu X, He L, et al
    Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Int J Cancer. 2018 Feb 16. doi: 10.1002/ijc.31323.
    >> Share

    January 2018
  5. INOUE-CHOI M, Hartge P, Liao LM, Caporaso N, et al
    Association between long-term low-intensity cigarette smoking and incidence of smoking-related cancer in the national institutes of health-AARP cohort.
    Int J Cancer. 2018;142:271-280.
    >> Share

    December 2017
  6. YU Y, Jin H, Xu J, Gu J, et al
    XIAP overexpression promotes bladder cancer invasion in vitro and lung metastasis in vivo via enhancing nucleolin-mediated Rho-GDIbeta mRNA stability.
    Int J Cancer. 2017 Dec 18. doi: 10.1002/ijc.31223.
    >> Share

  7. SHI X, Zhang X, Li J, Mo L, et al
    PD-1 blockade enhances the anti-tumor efficacy of GM-CSF surface-modified bladder cancer stem cells vaccine.
    Int J Cancer. 2017 Dec 15. doi: 10.1002/ijc.31219.
    >> Share

  8. WESTHOFF E, Wu X, Kiemeney LA, Lerner SP, et al
    Dietary patterns and risk of recurrence and progression in non-muscle-invasive bladder cancer.
    Int J Cancer. 2017 Dec 13. doi: 10.1002/ijc.31214.
    >> Share

    September 2017
  9. RAVA M, Czachorowski MJ, Silverman D, Marquez M, et al
    Asthma status is associated with decreased risk of aggressive urothelial bladder cancer.
    Int J Cancer. 2017 Sep 22. doi: 10.1002/ijc.31066.
    >> Share

  10. MASAOKA H, Matsuo K, Sawada N, Yamaji T, et al
    Alcohol consumption and bladder cancer risk with or without the flushing response: The Japan Public Health Center-based Prospective Study.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31028.
    >> Share

    July 2017
  11. BOTTERI E, Ferrari P, Roswall N, Tjonneland A, et al
    Alcohol consumption and risk of urothelial cell bladder cancer in the European Prospective Investigation into Cancer and Nutrition cohort.
    Int J Cancer. 2017 Jul 19. doi: 10.1002/ijc.30894.
    >> Share

    January 2017
  12. SOAVE A, Riethdorf S, Dahlem R, von Amsberg G, et al
    A nonrandomized, prospective, clinical study on the impact of circulating tumor cells on outcomes of urothelial carcinoma of the bladder patients treated with radical cystectomy with or without adjuvant chemotherapy.
    Int J Cancer. 2017;140:381-389.
    >> Share

    December 2016
  13. HADKHALE K, Martinsen JI, Weiderpass E, Kjaerheim K, et al
    Occupational exposure to solvents and bladder cancer: A population-based case control study in Nordic countries.
    Int J Cancer. 2016 Dec 29. doi: 10.1002/ijc.30593.
    >> Share

    June 2016
  14. ZHANG X, Zhang Y, Liu X, Liu T, et al
    Nested quantitative PCR approach for urinary cell-free EZH2 mRNA and its potential clinical application in bladder cancer.
    Int J Cancer. 2016 Jun 14. doi: 10.1002/ijc.30230.
    >> Share

  15. KISELYOV A, Bunimovich-Mendrazitsky S, Startsev V
    Key signaling pathways in the muscle-invasive bladder carcinoma: Clinical markers for disease modeling and optimized treatment.
    Int J Cancer. 2016;138:2562-9.
    >> Share

    January 2016
  16. RODRIGUES D, Jeronimo C, Henrique R, Belo L, et al
    Biomarkers in bladder cancer: A metabolomic approach using in vitro and ex vivo model systems.
    Int J Cancer. 2016 Jan 25. doi: 10.1002/ijc.30016.
    >> Share

    December 2015
  17. WANG M, Du M, Ma L, Chu H, et al
    A functional variant in TP63 at 3q28 associated with bladder cancer risk by creating a miR-140-5p binding site.
    Int J Cancer. 2015 Dec 22. doi: 10.1002/ijc.29978.
    >> Share

    October 2015
  18. MATULLO G, Naccarati A, Pardini B
    microRNA expression profiling in bladder cancer: The challenge of Next Generation Sequencing in tissues and biofluids.
    Int J Cancer. 2015 Oct 21. doi: 10.1002/ijc.29895.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016